Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2019 | 06-2018 | 06-2017 | 06-2016 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,525 | 4,254 | 8,284 | 8,146 | 15,343 |
| Receivables | 586 | 234 | 321 | 460 | 598 |
| Other current assets | 175 | 157 | 164 | 234 | 426 |
| TOTAL | $2,286 | $4,645 | $8,769 | $8,839 | $16,367 |
| Non-Current Assets | |||||
| PPE Net | 50 | 136 | 359 | 401 | 349 |
| Other Non-Current Assets | 0 | 0 | 0 | 443 | 616 |
| TOTAL | $50 | $136 | $359 | $844 | $965 |
| Total Assets | $2,335 | $4,781 | $9,128 | $9,683 | $17,332 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 719 | 733 | 677 | 611 | 923 |
| Other current liabilities | 349 | 392 | 428 | 360 | 464 |
| TOTAL | $1,068 | $1,125 | $1,105 | $971 | $1,452 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 65 |
| Other Non-Current Liabilities | 1 | 3 | 48 | 54 | 21 |
| TOTAL | $1 | $3 | $48 | $54 | $21 |
| Total Liabilities | $1,068 | $1,127 | $1,153 | $1,025 | $1,473 |
| Shareholders' Equity | |||||
| Retained earnings | -92,788 | -95,604 | -88,846 | -79,741 | -84,474 |
| Other shareholders' equity | 94,055 | 99,257 | 96,821 | 88,399 | 100,334 |
| TOTAL | $1,267 | $3,653 | $7,976 | $8,658 | $15,859 |
| Total Liabilities And Equity | $2,335 | $4,781 | $9,128 | $9,683 | $17,332 |